Protective effects of angiotensin II type-1 receptor blockade with olmesartan on spinal cord ischemia-reperfusion injury: An experimental study on rats

Annals of Vascular Surgery

Volumn 24, Issue 6, 2010, Pages 801-808

  Güler, Adem ^a   Ahin, Mehmet Ali ^a   Ucak, Alper ^a   Onan, Burak ^a   Inan, Kaan ^a   Özta, Emin ^a   Arslan, Sddk ^b   Uysal, Bülent ^a   Demirkl, Ufuk ^a   Tatar, Harun ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OLMESARTAN; SUPEROXIDE DISMUTASE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; NEUROPROTECTIVE AGENT; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA OCCLUSION; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFECT; GANGRENE; HISTOPATHOLOGY; MALE; NEUROLOGIC EXAMINATION; NONHUMAN; PARAPLEGIA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SCORING SYSTEM; SPINAL CORD ISCHEMIA; TREATMENT OUTCOME; ABDOMINAL AORTA; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; LIGATION; METABOLISM; MOTOR ACTIVITY; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD; SURGERY; TIME; WISTAR RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AORTA, ABDOMINAL; CONSTRICTION; DISEASE MODELS, ANIMAL; GLUTATHIONE PEROXIDASE; IMIDAZOLES; MALE; MALONDIALDEHYDE; MOTOR ACTIVITY; NECROSIS; NEUROPROTECTIVE AGENTS; PARAPLEGIA; RATS; RATS, WISTAR; REPERFUSION INJURY; SPINAL CORD; SPINAL CORD ISCHEMIA; SUPEROXIDE DISMUTASE; TETRAZOLES; TIME FACTORS;

EID: 77955625484     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2010.03.023     Document Type: Article

References (29)

1. J.S. Coselli, S.A. LeMaire, and C.C. Miller III Mortality and paraplegia after thoracoabdominal aortic aneurysm repair: a risk factor analysis Ann Thorac Surg 69 2000 409 414
2. E.S. Crawford, J.L. Crawford, and H.J. Safi Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients J Vasc Surg 3 1986 389 404
3. L.G. Svensson, and E.S. Crawford Cardiovascular and Vascular Disease of the Aorta 1997 Saunders Philadelphia
4. S. Buket, T. Yagdi, M. Cikirikcioglu, and M. Ozbaran Distal aort cerrahisi srasnda spinal kord korunmas S. Büket, T. Yagd, Aort Cerrahisi 2003 Yüce yaym Istanbul 65 132
5. T. Namikoshi, N. Tomita, and M. Satoh Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein Am J Hypertens 20 2007 1085 1091
6. H. Ando, J. Zhou, M. Macova, H. Imboden, and J.M. Saavedra Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats Stroke 35 2004 1726 1731 (Pubitemid 38823655)
7. N. Hosomi, A. Nishiyama, and C.R. Ban Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia Neuroscience 134 2005 225 231
8. H. Yamakawa, M. Jezova, H. Ando, and J.M. Saavedra Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition J Cereb Blood Flow Metab 23 2003 371 380
9. I.M. Tarlov Acute spinal cord compression paralysis J Neurosurg 36 1972 10 20
10. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
11. R.L. Levine, D. Garland, and C.N. Oliver Determination of carbonyl content in oxidatively modified proteins Methods Enzymol 186 1990 464 478
12. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 1979 351 358
13. Y. Sun, L.W. Oberley, and Y. Li A simple method for clinical assay of superoxide dismutase Clin Chem 34 1988 497 500
14. D.E. Paglia, and W.N. Valentine Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J Lab Clin Med 70 1967 158 169
15. R.J. Dumont, D.O. Okonkwo, and S. Verma Acute spinal cord injury, part I: pathophysiologic mechanisms Clin Neuropharmacol 24 2001 254 264 (Pubitemid 32906712)
16. D.C. Baptiste, and M.G. Fehlings Pharmacological approaches to repair the injured spinal cord J Neurotrauma 23 2006 318 334
17. X. Jiang, C. Ai, E. Shi, Y. Nakajima, and H. Ma Neuroprotection against spinal cord ischemia-reperfusion injury induced by different ischemic postconditioning methods: roles of phosphatidylinositol 3-kinase-Akt and extracellular signal-regulated kinase Anesthesiology 111 2009 1197 1205
18. M.S. Paller The cell biology of reperfusion injury in the kidney J Invest Med 42 1994 632 639
19. W. Fiers, R. Beyaert, W. DeclercQ, and P. Vandenabeele More than one way to die: apoptosis, necrosis, and reactive oxygen damage Oncogene 18 1999 7719 7730
20. K. Dobashi, B. Ghosh, J.K. Orak, I. Singh, and A.K. Singh Kidney ischemia-reperfusion: modulation of antioxidant defenses Mol Cell Biochem 205 2000 1 11
21. K.A. Nath, and S.M. Norby Reactive oxygen species and acute renal failure Am J Med 109 2000 655 678
22. J.M. Wang, J. Tan, and F.H. Leenen Central nervous system blockade by peripheral administration of AT1 receptor blockers J Cardiovasc Pharmacol 41 2003 593 599
23. T. Engelhorn, S. Goerike, and A. Doerfler The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats J Cereb Blood Flow Metab 24 2004 467 474
24. J.M. Saavedra, J. Benicky, and J. Zhou Mechanisms of the anti-ischemic effect of angiotensin II AT (1) receptor antagonists in the brain Cell Mol Neurobiol 26 2006 1099 1111
25. L. Yao, H. Kobori, and M. Rahman Olmesartan improves endothelin-induced hypertension and oxidative stress in rats Hypertens Res 27 2004 493 500
26. Y. Iwasaki, Y. Ichikawa, O. Igarashi, M. Kinoshita, and K. Ikeda Trophic effect of olmesartan, a novel AT1R antagonist, on spinal motor neurons in vitro and in vivo Neurol Res 24 2002 468 472
27. K. Yoshida, and M. Kohzuki Clinical and experimental aspects of olmesartan medoxomil, a new angiotensin II receptor antagonist Cardiovasc Drug Rev 22 2004 285 308
28. Q.J. Yu, Q.S. Zhou, H.B. Huang, Y.L. Wang, S.F. Tian, and D.M. Duan Protective Effect of Ketamine on Ischemic Spinal Cord Injury in Rabbits Ann Vasc Surg 22 2008 432 439
29. K.S. Helmer, Y. Cui, A. Dewan, and D.W. Mercer Ketamine/Xylazine attenuates LPS-induced iNOS expression in various rat tissues J Surg Res 112 2003 70 78